Pipeline

[anonymous]

What does the pipeline and hiring timelines look like here

 

[anonymous]

Very strong pipeline with much diversity. Neuro, ALS, Carsio, HAE, rare disease. It’s a very promising company!

 

[anonymous]

Very strong pipeline with much diversity. Neuro, ALS, Carsio, HAE, rare disease. It’s a very promising company!

I agree and up and comer. We’d be lucky to get a chance to work there

 

[anonymous]

I agree and up and comer. We’d be lucky to get a chance to work there

Are they hiring other teams here soon? Looking for field roles

 

[anonymous]

Stronger pipeline products are all partnered. Company has been around for over 40 years and never commercialized anything on their own. Anything they are commercializing had trouble finding a partner.

 

[anonymous]

Are they hiring other teams here soon? Looking for field roles

Yes they have a new field team they are anticipating hiring leaders starting Q1 and sales team Q2 2025.

 

[anonymous]

Yes they have a new field team they are anticipating hiring leaders starting Q1 and sales team Q2 2025.

They are preparing to move into a crowded market with no advantage over the current therapies. Ionis has always partnered their products and not built commercially. There is a reason this one has no partner.

 

[anonymous]

Stronger pipeline products are all partnered. Company has been around for over 40 years and never commercialized anything on their own. Anything they are commercializing had trouble finding a partner.

Not true. Not sure what you are reading but your facts are not accurate.

 

[anonymous]

They are preparing to move into a crowded market with no advantage over the current therapies. Ionis has always partnered their products and not built commercially. There is a reason this one has no partner.

There are multiple product launches happening not sure what you are refering to but the current launch market has no competitor so not sure what 'book' you're reading but unless you know, don't comment on bs and mislead others who might actually see the value coming here. Strong products many in the pipeline and Ionis is only looking to commercialize their products moving forward. Lots of opportunity starting to happen, people are seeing the value coming to Ionis.

 

[anonymous]

There are multiple product launches happening not sure what you are refering to but the current launch market has no competitor so not sure what 'book' you're reading but unless you know, don't comment on bs and mislead others who might actually see the value coming here. Strong products many in the pipeline and Ionis is only looking to commercialize their products moving forward. Lots of opportunity starting to happen, people are seeing the value coming to Ionis.

There was nothing untrue about the previous statement. The company has been in business for decades and has partnered their high potential products. Just look at their pipeline. Anything that is Ionis owned, either hasn't been partnered yet or there wasn't interest. Of the two drugs they are preparing to launch, one is in a tiny market of under 1000 patients with a competitor that also just filled with the FDA and the HAE drug has no true differentiation in the market.